Gas5 knockdown attenuated HFD-induced hepatic steatosis, reduced plasma triglyceride and cholesterol levels, and inhibited alanine aminotransferase and aspartate aminotransferase activities, all of which contributed to the reduced severity score of MASLD.40 Here, GAS5 is linked to fatty liver disease.